Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration—key factors ...
Zacks Investment Research on MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Zacks Investment Research on MSN
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Launched on June 19, 2006, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of ...
The State Street SPDR S&P Global Dividend ETF (WDIV) made its debut on 05/29/2013, and is a smart beta exchange traded fund that provides broad exposure to the Global Large-Cap Va ...
One fund leans into disruptive tech, while the other sticks to industry stalwarts—cost, volatility, and sector focus set them apart for investors.
SPDR S&P 500 ETF Trust (NYSEMKT: SPY) will always have a special place in the history of Wall Street. That's because the exchange-traded fund (ETF) was the first of its kind. But the ETF market has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results